Accession Number: | 0001127602-19-031732 |
Date: | 2019-11-01 |
Issuer: | MEDTRONIC PLC (MDT) |
Original Submission Date: |
COYLE MICHAEL J
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2019-11-01 | M | 37,774 | a | $38.81 | 226,036 | direct | ||
ORDINARY SHARES | 2019-11-01 | S | 37,774 | d | $109.50 | 188,262 | direct | ||
ORDINARY SHARES | 2019-11-01 | M | 1,202 | a | $41.60 | 189,464 | direct | ||
ORDINARY SHARES | 2019-11-01 | S | 1,202 | d | $109.50 | 188,262 | direct | ||
ORDINARY SHARES | 2019-11-01 | 0 | $0.00 | 250 | indirect | ||||
ORDINARY SHARES | 2019-11-01 | 0 | $0.00 | 4,104 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.81 | 2019-11-01 | deemed execution date | M | 37,774 (d) | 2022-07-30 | ordinary shares 37,774 | $38.81 | 37,774 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 41.6 | 2019-11-01 | deemed execution date | M | 1,202 (d) | 2022-10-29 | ordinary shares 1,202 | $41.60 | 1,202 | direct |
ID | footnote |
---|---|
f1 | the transactions reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan. |
f2 | this balance increased by 243 shares due to exempt transactions such as dividend reinvestment. |
f3 | this option to purchase 75,548 new medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 75,548 medtronic common stock shares for $38.81 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option. |
f4 | this option to purchase 2,404 new medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 2,404 medtronic common stock shares for $41.60 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option. |